It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2002.
2002 | Hyderabad, Telangana, India | ActiveSherrington Pharmaceuticals Private Limited, a active private limited company, was established on 09 October 2002 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TG2002PTC039741. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Its leadership includes Manogna Yeluri (Managing Director), Yeluri Hari Prasad (Director). Past directors included Manogna Yeluri, Yeluri Hari Prasad, Pasupathi Nadh Yeluri. It holds ₹76.09 Cr open charges and ₹1.62 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Avm Towers,No.4 2Nd Floor,Opp Kphb Col Near Shivaparvathi Theater, Kukatpally, Hyderabad, Telangana, 500072.
U24231TG2002PTC039741
039741
09 October 2002
₹0.50 M
₹0.20 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sherrington Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manogna Yeluri | Managing Director | 19 Aug 2019 | Current |
| Yeluri Hari Prasad | Director | 09 Oct 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Aug 2022 | Past |
| Pramod Abcsdd | Managing Director | 11 Aug 2022 | Past |
| Pramod Abcsdd | Director | 10 Oct 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sherrington Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.29% increase. The company also saw a substantial improvement in profitability, with a 25.31% increase in profit. The company's net worth Soared by an impressive increase of 18.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sherrington Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹760,879,444.00
₹16,240,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2022 | Hdfc Bank Limited | ₹2.11 M | Open |
| 03 Mar 2021 | Hdfc Bank Limited | ₹44.59 Cr | Open |
| 21 Sep 2017 | Others | ₹20.74 Cr | Open |
| 23 Aug 2011 | Ing Vysya Bank Limited | ₹8.55 Cr | Open |
| 28 Feb 2011 | Ing Vysya Bank Limited | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sherrington Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sherrington Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sherrington Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited of Rs. 445.87 M registered on 03 Mar 2021 with Charge ID 100424143 was modified on 19 Feb 2025. was completed.
Sherrington Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Sherrington Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.11 M with Charge ID 100593146 was registered on 30 Jun 2022. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 445.87 M with Charge ID 100424143 was registered on 03 Mar 2021. was documented.
Progress on Manogna Yeluri was appointed as a Managing Director was appointed as a Managing Director on 19 Aug 2019 & has been associated with this company since 6 years 3 months . was documented.
The CIN of Sherrington Pharmaceuticals Private Limited is U24231TG2002PTC039741.
Sherrington Pharmaceuticals Private Limited is headquartered at Avm Towers,No.4 2Nd Floor,Opp Kphb Col Near Shivaparvathi Theater, Kukatpally, Hyderabad, Telangana, 500072.
Sherrington Pharmaceuticals Private Limited was incorporated on 09 October 2002.
The current directors of Sherrington Pharmaceuticals Private Limited are
The primary industry of Sherrington Pharmaceuticals Private Limited is Manufacturing.
Sherrington Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sherrington Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.20 M.
The compliance status of Sherrington Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX